Critical Outcome Technologies Inc. (
www.criticaloutcome.com) founded by Dr. Wayne Danter M.D., is helping the pharmaceutical industry get drugs to market faster. The company has developed a proprietary technology platform called CHEMSAS® that allows for accelerated drug discovery. COTI is able to identify, profile and optimize small molecules years faster than the traditional pharmaceutical approach. The company has focused product development efforts on identifying potential treatments for diseases for which therapies are lacking or ineffective.
Whippoorwill (prior to the formation of Cassandra Capital) was primary seed investor in COTI and together with agents have facilitated a cumulative raise of approximately $7,000,000 in gross proceeds. COTI is a publicly traded company listed on the TSX Venture exchange (COT). John Drake is currently Chair and CEO.
